Diagnostics and therapy for normal tension glaucoma;Diagnostik und therapie des normaldruckglaukoms

Klinische Monatsblatter fur Augenheilkunde

Volumn 222, Issue 10, 2005, Pages 760-771

  Baleanu, Delia ^a   Michelson, G ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Endothelial dysfunction; Glaucoma; Neurovascular coupling; Normal tension glaucoma; Primary open angle glaucoma; White matter lesions

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; ASCORBIC ACID; BETAXOLOL; BRIMONIDINE; BROVINCAMINE; CALCIUM ANTAGONIST; CANDESARTAN HEXETIL; DORZOLAMIDE; GINKGO BILOBA EXTRACT; MELATONIN; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIMODIPINE; STATINE; XANTHOPHYLL; ZEAXANTHIN;

APOE GENE; ARTERIAL PRESSURE; BRAIN BLOOD FLOW; COLD PRESSOR TEST; DRUG EFFECT; ENDOTHELIUM CELL; EYE BLOOD FLOW; GENE; GENETIC POLYMORPHISM; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; OPEN ANGLE GLAUCOMA; OPTIC NERVE ATROPHY; PREVALENCE; REVIEW; WHITE MATTER;

EID: 27844592182     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858741     Document Type: Review

References (126)

1. Adult Treatment Panel III. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001; 285 (19): 2486-2497
2. Altan-Yaycioglu R, Turder G, Akdol S et al. The effects of beta-blockers os ocular blood flow in patients with primary open angle glaucoma: a color doppler imaging study. Eur J Ophthalmol 2001; 11: 37-46
3. Anderson DR, Drance SM, Schulzer M et al. Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol 2003; 136 (5): 820-829
4. Bartlett H, Eperjesi F. An ideal ocular nutritional supplement? Ophthal Physiol Opt 2004; 24: 339-349
5. Berendes R. Pulswellenanalyse der okulären Mikro- und Makrozirkulation: physiologische Grundlagen und Pathologie beim Glaukom. Erlangen, Nürnberg: Med. Dissertation 1998: 11-124
6. Bleich S, Junemann A, von Ahsen N et al. Homocysteine and risk of open-angle glaucoma. J Neural Transm 2002; 109(12): 1499-1504
7. Boles-Carenini A, Sibour G, Carenini BB. Differences in the longtermeffect of timolol and betaxolol on the pulsatile ocular blood flow. Surv Ophthalmol 1994; 38 (Suppl): 118-124
8. Bonomi L, Marchini G, Maraffa M. Vascular risk factors for primary open angle glaucoma. The Egna-Neumarkt Study. Ophthalmology 2000; 107: 1287-1293
9. Bonomi L, Marchini G, Marraffa M et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology 1998; 105 (2): 209-215
10. Buckley C, Hadoke P. Systemic vascular endothelial cell dysfunction in NPG. Br J Ophthalmol 2002; 86 (2): 227-232
11. Budde WM. Heredity in primary open-angle glaucoma. Curr Opin Ophthalmol 2000; 11: 101-106
12. Cadelo M, Inzitari D, Pracucci G et al. Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis 1991; 1: 345-351
13. Caprioli J, Spaeth GL. Comparison of the optic nerve head in high- and low-tension glaucoma. Arch Ophthalmol 1985; 103: 1145-1149
14. Chauhan BC, Drance SM, Douglas G et al. Visual field damage in normal tension and high tension glaucoma. Am J Ophthalmol 1989; 108: 636-642
15. Chung HS, Harris A, Kagemann L et al. Peripapillary retinal blood flow in normal tension glaucoma. Br J Ophthalmol 1999; 83: 466-469
16. Collaborative Normal-Tension Glaucoma Study Group. Comparison of Glaucomatous Progression between untreated patients with normaltension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487-497
17. Comoglu S, Yarangumeli A, Koz OG et al. Glaucomatous visual field defects in patients with migraine. J Neurol 2003; 250: 201-206
18. Cursiefen C, Wisse M, Cursiefen S et al. Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am J Ophthalmol 2000; 129: 102-104
19. de Leeuw FE, Richard F, de Groot J et al. Interaction between Hypertension, apoE, and cerebral white matter lesions. Stroke 2004; 35: 1057-1062
20. Delies C, Michelson G, Harazny J et al. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke 2004; 35 (6): 1289-1293
21. Dielemans I, de Jong PT, Stolk R et al. Primary openangle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology 1996; 103: 1271-1275
22. Dietlein TS, Jordan J, Jacobi PC et al. Profil einer universitären Glaukomsprechstunde. Ophthalmologe 2005; 102: 502-506
23. Dorner GT, Garhofer G, Huemer KH et al. Hyperglycemia affects flicker-induced vasodilatation in the retina of healthy subjects. Vision Research 2003; 43 (13): 1495-1500
24. Doshi SN, Goodfellow J, Lewis MJ et al. Homocysteine and endothelial function. Cardiovasc Res 1999; 42: 578-582
25. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001; 131: 699-708
26. European Glaucoma Society. Terminology and Guidelines for Glaucoma (IInd Edition). Editrice DOGMA s.r.l. 2003: Ch 2-5
27. Fassbender K, Mielke O, Bertsch T et al. Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999; 353: 1586-1593
28. Flammer J, Orgul S, Costa VP et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002; 21 (4): 359-393
29. Flammer J, Haefliger IO, Orgul S et al. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma 1999; 8: 212-219
30. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001; 20: 319-349
31. Fontana L, Poinoosawmy D, Bunce CV et al. Pulsatile ocular blood flow investigation in asymmetric normal tension glaucoma and normal subjects. Br J Ophthalmol 1998; 82: 731-736
32. Fuse N, Takahashi K, Akiyama H et al. Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population. J Glaucoma 2004; 13: 299-303
33. Gandolfi SA, Sangermani C, Cimino L et al. Is there a non-IOP-related effect of brimonidine on visual field progression in human glaucoma? ARVO Meeting 2004; Poster 2298
34. Garhofer G, Zawinka C, Resch H et al. Response of retinal vessel diameters to flicker stimulation in patients with early open angle glaucoma. J Glaucoma 2004; 13 (4): 340-344
35. Geijssen HC. Studies on normal pressure glaucoma. Amsterdam: Kugler, 1991: 1: 1
36. Ghiadoni L, Virdis A, Magagna A et al. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension 2000; 35: 501-506
37. Graham SL, Drance SM, Wijsman K et al. Ambulatory blood pressure monitoring in glaucoma patients: The nocturnal dip. Ophthalmology 1995: 61-69
38. Grodum K, Heijl A, Bengtsson B. A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthalmol Scand 2002; 80 (6): 627-631
39. Groh MJ, Michelson G, Harazny J et al. Changes in retinal blood flow by topical administration of 0.1% dipivefrin. Ophthalmologe 1999; 96 (11): 706-710
40. Grus FH, Joachim SC, Hoffmann EM et al. Complex autoantibody repertoires in patients with glaucoma. Mol Vis 2004; 25 (10): 132-137
41. Harazny J, Michelson G. Ocular Cold Presser Test - New diagnostic test in patients with normal tension glaucoma. Klin Monatsbl Augenheilkd 1999; Annual Meeting of the Bavarian Ophthalmology Society, Erlangen 26-27.11 1999: 215 (Suppl 11): 8
42. Harazny J. Zirkulation des Auges bei Patienten mit Normaldruckglaukomen. Erlangen, Nürnberg: Inauguraldissertation 2001
43. Harju M, Vesti E. Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol 2001; 239: 271-277
44. Harris A, Arend O, Chung HS et al. A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma pacients. Ophthalmology 2000; 107: 430-434
45. Hassan A, Hunt BJ, O'Sullivan M et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127(1): 212-219
46. Hayreh SS. The role of age and cardiovascular disease in glaucomatous optic neuropathy. Surv Ophthalmol 1999; 43 (Suppl 1): S27-S42
47. Hayreh SS, Zimmerman MB, Podhajsky P et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117: 603-624
48. Henon H, Vroylandt P, Durieu I et al. Leukoaraiosis More Than Dementia Is a Predictor of Stroke Recurrence. Stroke 2003; 34: 2935-2940
49. Henry E, Newby DE, Webb DJ et al. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci 1999; 40: 1710-1714
50. Husson I, Mesples B, Bac P et al. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002; 51 (1): 82-92
51. Inzitari D, Giordano GP, Ancona AL et al. Leukoaraiosis, intracerebral hemorrhage, and arterial hypertension. Stroke 1990; 21: 1419-1423
52. Javitt JC, Spaeth GL, Katz LJ et al. Acquired pits of the optic nerve. Increased prevalence in patients with low-tension glaucoma. Ophthalmology 1990; 97: 1038-1043
53. John S, Schneider MP, Delles C et al. Lipidindependent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterinemic patients. Am Heart J 2005; 149 (3): 473
54. Kaiser HJ, Flammer J. Systemic hypotension: risk factor for glaucomatous damage? Ophthalmologica 1991; 203: 105-108
55. Kaiser HJ, Flammer J, Graf T et al. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 1993; 231: 677-680
56. Kamal D, Hitchings R. Normal tension glaucoma - a practical approach. Br J Ophthalmol 1998; 82 (7): 835-840
57. Kang JH, Pasquale LR, Wilett WC et al. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr 2004; 79: 755-764
58. Kario K, Matsuo T, Kobayashi H et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: advanced silent cerebro-vascular damage in extreme dippers. Hypertension 1996; 27: 130-135
59. Kario K, Montai K, Mitsuhashi T et al. Autonomic nervous system dysfunction in elderly hypertensive patients with abnormal diurnal blood pressure variation: relation to silent cerebrovascular disease. Hypertension 1997; 30: 1504-1510
60. Kitasawa Y, Shirai H, Go FJ. The Effect of Ca2 +-antagonists on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989; 227: 408-412
61. Klein BEK, Klein R, Sponsel WE et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 1499-1504
62. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology 1994; 101: 1173-1177
63. Klingbeil AU, John S, Schneider MP et al. Effect of ATI receptor blockade on endothelial function in essential hypertension. Am J Hypertens 2003; 16: 123-128
64. Koseki N, Araie M, Yamagami J et al. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure. J Glaucoma 1999; 8(2): 117-123
65. Kruit MC, van Buchem MA, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 29 (4): 427-434
66. Leblhuber F, Walli J, Artner-Dworzak E et al. Hyperhomocysteinemia in dementia. J Neural Transm 2000; 107: 1469-1474
67. Lebuisson DA, Leroy L, Rigal G. Treatment of senile macular degeneration with Ginkgo biloba extract - preliminary double-blind, drug vs placebo study. Presse Med 1986; 15: 1556-1558
68. Levene R. Low tension glaucoma: a critical review and new material. Surv Ophthalmol 1980; 61: 621-664
69. Longstreth WT Jr, Manolio TA, Arnold A et al for the Cardiovascular Health Study Collaborative Research Group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-1282
70. McGwin G Jr, McNeal S, Owsley C et al. Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 2004; 122(6): 822-826
71. Michalk F, Michelson G, Harazny J et al. Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma. J Glaucoma 2004; 13(2): 158-162
72. Michelson G, Schmauss B. Two dimensional mapping of the perfusion of the retina and optic nerve head. Br J Ophthalmol 1995; 79: 1126-1132
73. Michelson G, Welzenbach J, Pal I et al. Automatic full field analysis of perfusion images gained by scanning laser Doppler flowmetry. Br J Ophthalmol 1998; 82 (11): 1294-1300
74. Michelson G, Patzelt A, Harazny J. Flickering light increases retinal blood flow. Retina 2002; 22 (3): 336-343
75. Michelson G, Welzenbach J, Pal I et al. Functional Imaging of the Retinal Microvasculature by Scanning Laser Doppler Flowmetry. International Ophthalmology 2001; 23 (4-6): 327-335
76. Miller KM, Quigley HA. Comparison of optic disc features in low-tension and typical open-angle glaucoma. Ophthalmic Surg 1987; 18: 882-889
77. Mitchell P, Smith W, Chey T et al. Open-angle glaucoma and diabetes. The Blue Mountains eye study, Australia. Ophthalmology 1997; 10: 712-718
78. Mitchell P, Lee AJ, Rochtchina E et al. Open-angle glaucoma and systemic hypertension: The Blue Mountains Eye Study. J Glaucoma 2004; 13: 319-326
79. Monemi S, Spaeth G, DaSilva A et al. Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22. Human Molecular Genetics 2005; 14: 725-733
80. Morsman CD, Bosem ME, Lusky M et al. The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow. Eye 1995; 9 (3): 344-347
81. Motolko M, Drance SM, Douglas GR. Visual field defects in low-tension glaucoma. Comparison of defects in low-tension glaucoma and chronic open angle glaucoma. Arch Ophthalmol 1982; 100: 1074-1077
82. Nebes RD, Vora IJ, Meltzer CC et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am J Psychiatry 2001; 158: 878-884
83. Ong K, Farinelli A, Billson F et al. Comparative study of brain magnetic resonance imaging findings in patients with low-tension glaucoma and control subjects. Ophthalmology 1995; 102: 1632-1638
84. Pei Z, Cheung RT. Melatonin protects SHSY5Y neuronal cells but not cultured astrocytes from ischemia due to oxygen and glucose deprivation (abstract). J Pineal Res 2003; 34: 194-201
85. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci 1985; 26: 1105-1108
86. Pillunat LE, Bohm AG, Koller AU et al. Effect of topical dorzolamide on optic nerve head blood flow. Graefes Arch Clin Exp Ophthalmol 1999; 237: 495-500
87. Piltz JR, Bose S, Lanchoney D. The effect of nimodipine, a centrally active calcium antagonist, on visual function and macular blood flow in patients with normal-tension glaucoma and control subjects. J Glaucoma 1998; 7: 299-300
88. Pogorelov P. Wanddickenmessung retinaler Gefäße mittels Scanning-Laser-Doppler-Flowmetrie bei Gesunden und bei Patienten mit arterieller Hypertonie. Erlangen: Medizinische Dissertation, 2003
89. Pogorelov P, Michelson G, Harazny J et al. Measurement of Retinal Vessel Wall Thickness with Scanning-laser Doppler Flowmetry in Healthy Persons and in Patients with Arterial Hypertension. DOG Tagung 2003; Poster
90. Quaranta L, Bettelli S, Uva MG et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003; 110: 359-362
91. Rezaie T, Child A, Hitchings R et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002; 295: 1077-1079
92. Riva CE, Harino S, Shonat RD et al. Flicker evoked increase in optic nerve head blood flow in anesthetized cats. Neurosci Lett 1991; 128: 291-296
93. Riva CE, Falsini B, Logean E. Blood flow responses of the human optic nerve to luminance and chromatic flicker: correlation with magno- and parvocellular neural activity. Vision Science and Its Applications. Optical Society of America Technical Digest 2000: 43-46
94. Rouhiainen HJ, Terasvirta ME. Haemodynamic variables in progressive and non-progressive low tension glaucoma. Acta Ophthalmol 1990; 68: 34-36
95. Sack J, Healey DL, de Graaf AP et al. The problem of overlapping glaucoma families in the Glaucoma Inheritance Study in Tasmania (GIST). Ophthalmic Genet 1996; 17: 209-214
96. Sampaolesi J, Tosi J, Darchuk V et al. Antiglaucomatous drugs effects on optic nerve head flow: design, baseline and preliminary report. Int Ophthalmol 2001; 23: 359-367
97. Schmetterer L, Findl O, Fasching P et al. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes 1997; 46: 653-658
98. Schmidt KG, von Ruckmann A, Pillunat LE. Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma. Br J Ophthalmol 1998; 82: 758-762
99. Sellmayer A, Schrepf R, Theisen K et al. Stellenwert von Omega-3-Fettsäuren in der kardiovaskulären Prävention. Dtsch Med Wochenschr 2004; 129: 1993-1996
100. Soares AS, Artes PH, Andreou P et al. Factors associated with optic disc hemorrhages in glaucoma. Ophthalmology 2004; 111: 1653-1657
101. Sponsel WE, Paris G, Trigo Yet al. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal antiinflammatory therapy. Am J Ophthalmol 2002; 133: 11-18
102. Stewart WC, Osterman J. Serum lipid physiology and the influence of glaucoma medications. Surv Ophthalmol 1998; 43: 233-244
103. Stroman GA, Stewart WC, Kolnik KC et al. Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmology 1995; 113: 168-172
104. Sugiyama T, Schwartz B, Takamoto T et al. Evaluation of the circulation in the retina, peripapillary choroid and optic disk in normal-tension glaucoma. Ophthalmic Res 2000; 32: 79-86
105. Suzuki J, Tomidokoro A, Araie M et al. Visual field damage in normaltension glaucoma patients with or without ischemic changes in cerebral magnetic resonance imaging. Jpn J Ophthalmol 2004; 48: 340-344
106. Szapary L, Horvath B, Marton Z et al. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia (abstract). CNS Drugs 2004; 18: 165-172
107. Tezel G, Kass MA, Kolker AE et al. Comparative optic disc analysis in normal pressure glaucoma, primary open angle glaucoma, and ocular hypertension. Ophthalmology 1996; 103: 2105-2113
108. Tielsch JM, Katz J, Sommer A et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population based assessment. Arch Ophthalmol 1995; 113: 216-221
109. Tokunaga T, Kashiwagi K, Tsumura T et al. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol 2004; 48: 380-385
110. Tomita G, Niwa Y, Shinohara H et al. Changes in the optic nerve head blood flow and retrobulbar hemodynamics following calcium-channel blocker treatment of normal-tension glaucoma. Int Ophthalmol 1999; 23: 3-10
111. Turacli ME, Ozden RG, Curses MA. The effect of betaxolol on ocular blood.ow and visual fields in patients with normotension glaucoma. Eur J Ophthalmol 1998; 8: 62-66
112. Tuulonen A, Airaksinen PJ. Optic disc size in exfoliative, primary open angle, and low-tension glaucoma. Arch Ophthalmol 1992; 110: 211-213
113. Tutaj M, Brown CM, Brys M et al. Dynamic cerebral autoregulation is impaired in glaucoma. J Neurol Sci 2004; 220: 49-54
114. van der Valk R, Webers CA, Schouten JS et al. Intraocular Pressure-Lowering Effects of All Commonly Used Glaucoma Drugs. A Meta-analysis of Randomized Clinical Trials. Ophthalmology 2005; 112 (7): 1177-1185
115. Vermeer SE, Hollander M, van Dijk EJ et al. Silent Brain Infarcts and White Matter Lesions increase Stroke Risk in the General Population. The Rotterdam Scan Study. Stroke, 2003; 34: 1126-1129
116. Vessani RM, Ritch R, Liebmann JM et al. Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 2003; 136: 41-46
117. Vetrugno M, Maino A, Cantatore F et al. Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an open-label, uncontrolled, prospective study. Clin Ther 2001; 23: 1519-1528
118. Vickers JC, Craig JE, Stankovich J et al. The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis 2002; 8: 389-393
119. Waldmann E, Gasser P, Dubler B et al. Silent myocardial ischemia in glaucoma and cataract patients. Graefes Arch Clin Exp Ophthalmol 1996; 234: 595-598
120. Weisschuh N, Neumann D, Wolf C et al. Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients. Molecular Vision 2005; 11: 284-287
121. Wolde-Mussie E, Yoles E, Schwartz M et al. Neuroprotective Effect of Memantine in Different Retinal Injury Models in Rats. J Glaucoma 2002; 11: 474-480
122. Wolf S, Arend O, Schulte K et al. Quantification of retinal capillary density and flow velocity in patients with essential hypertension. Hypertension 1994; 23: 464-467
123. Wong TY, Klein R, Sharett AR et al. The Atherosclerosis in Communities Study. Cerebral white matter lesions, retinopathy and incident clinical stroke. JAMA 2002; 288: 67-74
124. Wood JP, Schmidt KG, Melena J et al. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res 2003; 76: 505-516
125. Yamazaki Y, Drance SM. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol 1997; 124: 287-295
126. Zeitz O, Matthiessen ET, Reuss J et al. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN 18873428]. BMC Ophthalmol 2005; 5: 6